Cholesterol as a determinant of cooperativity in the M2 muscarinic cholinergic receptor

Biochemical Pharmacology

Volumn 74, Issue 2, 2007, Pages 236-255

  Colozo, Alejandro T ^a   Park, Paul S H ^a   Sum, Chi Shing ^a   Pisterzi, Luca F ^a   Wells, James W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cholesterol; Cooperativity; G protein coupled receptor; M2 muscarinic cholinergic receptor; Mechanistic models; Oligomers

Indexed keywords

BETA CYCLODEXTRIN; CHOLESTEROL; CHOLINERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; METHYLSCOPOLAMINE; MUSCARINIC M2 RECEPTOR; QUINUCLIDINYL BENZILATE; TRITIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG RECEPTOR BINDING; ELECTROPHORESIS; EXTRACTION; INCUBATION TIME; INSECT CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SARCOLEMMA; STATISTICAL ANALYSIS; TEMPERATURE DEPENDENCE; WESTERN BLOTTING;

ANIMALS; CHOLESTEROL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; N-METHYLSCOPOLAMINE; QUINUCLIDINYL BENZILATE; RECEPTOR, MUSCARINIC M2; SPODOPTERA;

EID: 34249985503     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.04.009     Document Type: Article

References (71)

1. Milligan G. Oligomerization of G protein-coupled receptors. J Cell Sci 114 (2001) 1265-1271
2. Park P.S., Filipek S., Wells J.W., and Palczewski K. Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 43 (2004) 15643-15656
3. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26 (2005) 131-137
4. Chidiac P., and Wells J.W. Effects of adenyl nucleotides and carbachol on cooperative interactions among G proteins. Biochemistry 31 (1992) 10908-10921
5. Wreggett K.A., and Wells J.W. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem 270 (1995) 22488-22499
6. Chidiac P., Green M.A., Pawagi A.B., and Wells J.W. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. Biochemistry 36 (1997) 7361-7379
7. Birnbaumer L., Abramowitz J., and Brown A.M. Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031 (1990) 163-224
8. Berrie C.P., Birdsall N.J., Hulme E.C., Keen M., and Stockton J.M. Solubilization and characterization of guanine nucleotide-sensitive muscarinic agonist binding sites from rat myocardium. Br J Pharmacol 82 (1984) 853-861
9. Ross E.M., Maguire M.E., Sturgill T.W., Biltonen R.L., and Gilman A.G. Relationship between the β-adrenergic receptor and adenylate cyclase. J Biol Chem 252 (1977) 5761-5775
10. Birdsall N.J., Burgen A.S., and Hulme E.C. The binding of agonists to brain muscarinic receptors. Mol Pharmacol 14 (1978) 723-736
11. De Lean A., Stadel J.M., and Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255 (1980) 7108-7117
12. Stiles G.L., Caron M.G., and Lefkowitz RJ. β-Adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64 (1984) 661-743
13. Haga K., and Haga T. Purification of the muscarinic acetylcholine receptor from porcine brain. J Biol Chem 260 (1985) 7927-7935
14. Levitzki A. β-Adrenergic receptors and their mode of coupling to adenylate cyclase. Physiol Rev 66 (1986) 819-854
15. Peterson G.L., Rosenbaum L.C., Broderick D.J., and Schimerlik M.I. Physical properties of the purified cardiac muscarinic acetylcholine receptor. Biochemistry 25 (1986) 3189-3202
16. Lee T.W., Sole M.J., and Wells J.W. Assessment of a ternary model for the binding of agonists to neurohumoral receptors. Biochemistry 25 (1986) 7009-7020
17. Green M.A., Chidiac P., and Wells J.W. Cardiac muscarinic receptors. Relationship between the G protein and multiple states of affinity. Biochemistry 36 (1997) 7380-7394
18. Limbird L.E., Meyts P.D., and Lefkowitz R.J. β-Adrenergic receptors: evidence for negative cooperativity. Biochem Biophys Res Commun 64 (1975) 1160-1168
19. Limbird L.E., and Lefkowitz R.J. Negative cooperativity among β-adrenergic receptors in frog erythrocyte membranes. J Biol Chem 251 (1976) 5007-5014
20. 2 receptor. J Biol Chem 273 (1998) 1309-1315
21. 2 dopamine receptor. Mol Pharmacol 69 (2006) 226-235
22. Mattera R., Pitts B.J., Entman M.L., and Birnbaumer L. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. J Biol Chem 260 (1985) 7410-7421
23. Boyer J.L., Martinez-Carcamo M., Monroy-Sanchez J.A., Posadas C., and Garcia-Sainz J.A. Guanine nucleotide-induced positive cooperativity in muscarinic-cholinergic antagonist binding. Biochem Biophys Res Commun 134 (1986) 172-177
24. 2 antagonists. Biochemistry 24 (1985) 6107-6115
25. Jordan B.A., and Devi L.A. G protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
26. 2-adrenergic receptor heterodimers. Can J Physiol Pharmacol 81 (2003) 186-195
27. Henis Y.I., and Sokolovsky M. Muscarinic antagonists induce different receptor conformations in rat adenohypophysis. Mol Pharmacol 24 (1983) 357-365
28. 3H]histamine. Biochemistry 24 (1985) 6095-6107
29. 3H]histamine in guinea pig cerebral cortex. II. Mechanistic basis for multiple states of affinity [corrected]. Mol Pharmacol 43 (1993) 583-594
30. El-Asmar L., Springael J.Y., Ballet S., Andrieu E.U., Vassart G., and Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67 (2005) 460-469
31. Park P.S., Sum C.S., Pawagi A.B., and Wells J.W. Cooperativity and oligomeric status of cardiac muscarinic cholinergic receptors. Biochemistry 41 (2002) 5588-5604
32. 2 receptor dimer formation: evidence from ligand binding. J Biol Chem 276 (2001) 22621-22629
33. 2 acetylcholine receptors in Sf9 cells. Eur J Pharmacol 421 (2001) 11-22
34. 2 muscarinic cholinergic receptor. J Neurochem 90 (2004) 537-548
35. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol Life Sci 57 (2000) 1577-1592
36. Marheineke K., Grunewald S., Christie W., and Reilander H. Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett 441 (1998) 49-52
37. Klein U., Gimpl G., and Fahrenholz F. Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34 (1995) 13784-13793
38. 2 muscarinic cholinergic receptor purified from Sf9 cells. Biochemistry 42 (2003) 12960-12971
39. Rasband WS. ImageJ. U.S. National Institutes of Health, Bethesda, Maryland, USA, 1997-2006. http://rsb.info.nih.gov/ij.
40. Wells J.W. Analysis and interpretation of binding at equilibrium. In: Hulme E.C. (Ed). Receptor-ligand interactions: a practical approach (1992), Oxford University Press, Oxford 289-395
41. Sum C.S., Pyo N., and Wells J.W. Apparent capacity of cardiac muscarinic receptors for different radiolabeled antagonists. Biochem Pharmacol 62 (2001) 829-851
42. Marquardt D.W. An algorithm for least-squares estimation of nonlinear parameters. J Soc Ind Appl Math 11 (1963) 431-441
43. Motulsky H.J., and Christopoulos A. Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting (2003), Graphpad Software Inc., San Diego
44. Sum C.S., Park P.S., and Wells J.W. Effects of N-ethylmaleimide on conformational equilibria in purified cardiac muscarinic receptors. J Biol Chem 277 (2002) 36188-36203
45. Gaudin Y., Barge A., Ebel C., and Ruigrok R.W. Aggregation of VSV M protein is reversible and mediated by nucleation sites: implications for viral assembly. Virology 206 (1995) 28-37
46. Majhi P.R., Ganta R.R., Vanam R.P., Seyrek E., Giger K., and Dubin P.L. Electrostatically driven protein aggregation: β-lactoglobulin at low ionic strength. Langmuir 22 (2006) 9150-9159
47. Klco J.M., Lassere T.B., and Baranski T.J. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J Biol Chem 278 (2003) 35345-35353
48. 2-adrenergic receptor dimers and oligomers. Biol Chem 384 (2003) 117-123
49. Liang Y., Fotiadis D., Filipek S., Saperstein D.A., Palczewski K., and Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278 (2003) 21655-21662
50. Kwok-Keung F.B., and Stryer L. Photolyzed rhodopsin catalyzes the exchange of GTP for bound GDP in retinal rod outer segments. Proc Natl Acad Sci USA 77 (1980) 2500-2504
51. Gray-Keller M.P., Biernbaum M.S., and Bownds M.D. Transducin activation in electropermeabilized frog rod outer segments is highly amplified, and a portion equivalent to phosphodiesterase remains membrane-bound. J Biol Chem 265 (1990) 15323-15332
52. Monod J., Wyman J., and Changeaux J.P. On the nature of allosteric transitions: a Plausible model. J Mol Biol 12 (1965) 88-118
53. Sourjik V., and Berg H.C. Functional interactions between receptors in bacterial chemotaxis. Nature 428 (2004) 437-441
54. Bray D., and Duke T. Conformational spread: the propagation of allosteric states in large multiprotein complexes. Annu Rev Biophys Biomol Struct 33 (2004) 53-73
55. van Holde K.E., Miller K.I., and van Olden E. Allostery in very large molecular assemblies. Biophys Chem 86 (2000) 165-172
56. Gimpl G., Klein U., Reilander H., and Fahrenholz F. Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry 34 (1995) 13794-13801
57. Pang L., Graziano M., and Wang S. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry 38 (1999) 12003-12011
58. Reversi A., Rimoldi V., Brambillasca S., and Chini B. Effects of cholesterol manipulation on the signaling of the human oxytocin receptor. Am J Physiol Regul Integr Comp Physiol 291 (2006) R861-R869
59. Chen X., and Resh M.D. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 277 (2002) 49631-49637
60. Lagane B., Gaibelet G., Meilhoc E., Masson J.M., Cezanne L., and Lopez A. Role of sterols in modulating the human μ-opioid receptor function in Saccharomyces cerevisiae. J Biol Chem 275 (2000) 33197-33200
61. Pucadyil T.J., and Chattopadhyay A. Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochim Biophys Acta 1714 (2005) 35-42
62. Gimpl G., and Fahrenholz F. Cholesterol as stabilizer of the oxytocin receptor. Biochim Biophys Acta 1564 (2002) 384-392
63. Chini B., and Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?. J Mol Endocrinol 32 (2004) 325-338
64. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
65. Guzzi F., Zanchetta D., Cassoni P., Guzzi V., Francolini M., Parenti M., et al. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene 21 (2002) 1658-1667
66. Rimoldi V., Reversi A., Taverna E., Rosa P., Francolini M., Cassoni P., et al. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene 22 (2003) 6054-6060
67. 2AChR to sarcolemmal caveolae and eNOS activation. Life Sci 64 (1999) 471-477
68. 2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272 (1997) 17744-17748
69. Albert A.D., Young J.E., and Yeagle P.L. Rhodopsin-cholesterol interactions in bovine rod outer segment disk membranes. Biochim Biophys Acta-Biomembr 1285 (1996) 47-55
70. Mitchell D.C., Straume M., Miller J.L., and Litman B.J. Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry 29 (1990) 9143-9149
71. Politowska E., Kazmierkiewicz R., Wiegand V., Fahrenholz F., and Ciarkowski J. Molecular modelling study of the role of cholesterol in the stimulation of the oxytocin receptor. Acta Biochim Pol 48 (2001) 83-93